Shockwave Medical, Inc. SWAV recently announced the full U.S. commercial availability of the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This follows the receipt of the FDA’s ...
Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral artery disease (PAD). This new intravascular lithotripsy (IVL) platform is ...
Shockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries Shockwave C2+ is commercially available for the treatment of de novo coronary artery disease in Europe and select other ...
Johnson & Johnson has announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, an intravascular lithotripsy (IVL) platform aimed at addressing calcium buildup in severely ...
SANTA CLARA, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
The company hopes to use the proceeds to bolster its marketing activities in the U.S. and abroad, including expanding its sales and commercialization staff. (Shockwave) () 2015 Fierce 15 company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results